Stent price control was a short-sighted move, right? Here’s how
Eight months ago, the drug regulator cut down hospitals’ margins. Now, the hospitals are making up for the lost revenue leaving the patient helpless
Hospitals have increased the price for angioplasty procedures by as much as 45% to make up for the loss of revenue
They have also started negotiating medical procedure prices with health insurance companies
Abbott has withdrawn two high-end stents from the Indian market and the supply of latest stents is also limited
The patients, who have undergone angioplasty at government-funded hospitals, are not affected by price control of stents
As far as the popularity of any health policy goes, price ceiling for stents has made it right to the top. Just before Uttar Pradesh elections, Prime Minister Narendra Modi used it at a rally to woo the voters. The PM claimed that he was committed to providing affordable healthcare to everyone by reprimanding and controlling the profit-motivated businesses. Only if its simplicity and popularity made healthcare affordable.
Eight months later, the cheer from the crowds is followed by some behind-the-door discussion in fine print. Hospitals’ message: you…
Read the full story now. Subscribe to The Ken
Stories on The Ken are available only for its subscribers. Join us now to get instant access.
Complete access to all stories on The Ken. Rs. 2,750/year or Rs. 1,200/quarter
Dear subscriber - a lot of hard work goes into the journalism we put out. While sharing snippets or limited screenshots is okay, please avoid printing and sharing our entire articles as PDFs. Our plans are very affordable - please ask your friends to subscribe.